CARB-X Funds Development of POC Home Test for Gonorrhea and Chlamydia
Scout received funding to develop a test to detect and differentiate between Neisseria gonorrhoeae and Chlamydia trachomatis quickly.
Scout received funding to develop a test to detect and differentiate between Neisseria gonorrhoeae and Chlamydia trachomatis quickly.
The FDA granted marketing authorization to a diagnostic test for chlamydia and gonorrhea with at-home sample collection.
New research found that STI and HIV testing declined at the onset of the COVID pandemic, while there was an increase in positive test rates.
Black sexual minority men who give and receive support within their social networks are more likely to be tested for syphilis.
Read MoreChembio announced the submission to the FDA for a Clinical Laboratory Improvement Amendments waiver for the DPP HIV-Syphilis System.
Read MoreBacterial vaginosis and trichomoniasis results in a range of health complications. A test-and-treat approach can improve diagnosis.
Read MoreThe New York-based Arthur Ashe Institute for Urban Health (AAIUH), and Florida-based IMG Helps (IMGH), have formed the AAIUH X IMGH alliance.
Read MoreA study of patients receiving care for HIV has identified the four steps that can be taken to identify more sexually transmitted infections.
Read MoreLaboratories are well-positioned to meet STI testing demands during the current surge of sexually transmitted diseases in the U.S.
Read MoreWith demand for monkeypox testing, labs will need to be aware of the regulations related to coding, reimbursement, and compliance issues.
Read MoreStudy revealed Lucira’s testing assays offer a 98% accuracy rate in detecting the two sexually transmitted infections.
Read MoreBD and CerTest Biotec have announced their newly developed molecular polymerase chain reaction or PCR assay for monkeypox virus is available.
Read MorePsomagen Incorporated and Kean Health announced the launch of Kean V and Kean V+, a vaginal microbiome test.
Read MoreThe Oklahoma State Public Health Laboratory transferred to a new facility in the midst of the COVID-19 crisis.
Read MoreKeystone Laboratories will now be testing hepatitis and HIV panels at its in-house lab located in Asheville, North Carolina.
Read MoreWith patients catching up on diagnostic tests, labs are being overwhelmed with demand. Technology can help increase lab workflow efficiency.
Read MoreAbbott has received FDA clearance for its Alinity m STI Assay, which simultaneously detects and differentiates four common STIs.
Read MoreNew data from the Centers for Disease Control and Prevention (CDC) shows a massive increase in sexually transmitted infections (STI) rates.
Read More